id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-1995-0005,FDA,FDA-2020-E-1995,Determination of Regulatory Review Period for Purposes of Patent Extension; NOURIANZ,Notice,Determinations,2022-11-07T05:00:00Z,2022,11,2022-11-07T05:00:00Z,2023-01-07T04:59:59Z,2022-11-07T18:21:13Z,2022-24217,0,0,0900006485492c81
FDA-2020-E-1995-0004,FDA,FDA-2020-E-1995,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2022-09-22T04:00:00Z,2022,9,2022-09-22T04:00:00Z,,2022-09-22T17:41:03Z,,0,0,0900006485350c90